Webinar: Recruitment Remedies
How to avoid recruitment barriers, from planning to rescuing clinical trials
In partnership with BioLink Intelligence
Webinar: Recruitment Remedies
How to avoid recruitment barriers, from planning to rescuing clinical trials
In partnership with BioLink Intelligence
About the webinar
Date: 8 April 2024
Time: 15:30 PM CEST | 9:30 AM ET
Avoidable recruitment bottlenecks can cost sponsors up to $8M a day in lost sales; join BioLink and Clariness, with guest speakers from leading biopharmaceutical companies, as we discuss ‘recruitment remedies’ for clinical trials, whether you’re planning a trial or have one in need of rescue as of yesterday.
The speakers:
- Dr. Uli Broedl, Corporate Senior Vice President and Head of Global Clinical Development & Operations, Boehringer Ingelheim
- Dr. Joerg Moeller, Chief Executive Officer and Executive Board Member, BenevolentAI
- Dr. Joachim Luithle, Managing Director, BioLink Intelligence
- Dilek Denizli, VP Patient Recruitment Strategy, Clariness
Chairperson:
- Michael Stadler, Co-founder & CEO, Clariness
The webinar has concluded, but you can still catch all the valuable insights by downloading the recording here:
Meet the speakers
Dr Uli Brödl
Uli Broedl, MD, is Corporate Senior Vice President and Head of Global Clinical Development & Operations at Boehringer Ingelheim. He is passionate about research, development, and digital innovation to improve patient access and care. He steers Boehringer Ingelheim’s global Medicine Excellence Transformation to accelerate Clinical Development timelines and to create holistic Clinical Development stakeholder (regulator-payer-patient) evidence, a comprehensive global approach integrating people & culture, digital and business transformation initiatives.
Dr Jörg Möller
Dr Joerg Moeller is the Chief Executive Officer and Executive Board Member of BenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery. With over 30 years of experience in the pharmaceutical industry, Dr. Moeller has a proven track record of developing and launching innovative and competitive drugs in various therapeutic areas, such as cardiovascular, oncology, hematology, ophthalmology, women’s health, dermatology and infectious diseases.
Dr Joachim Luithle
Dr Joachim Luithle is passionate about Clinical Research and co-founder of BioLink Intelligence a company that enables Biopharmaceutical companies to plan and execute professional Clinical Research. He is an experienced Senior Executive in Pharmaceutical Research and Development with extensive knowledge of clinical development processes, digital technologies, and a track record of operational over delivery. He led modernization of clinical trial conduct to transform patient health at Bayer as Senior Vice President of Clinical Joachim Luithle Operations an organization active in 45 countries.
Dilek Denizli
Dilek Denizli, VP Patient Recruitment Strategy at Clariness, is an accomplished leader in patient enrollment. Dilek managed trials at Parexel for 10 years, specializing in developing and implementing patient engagement and enrollment strategies, as well as identifying and qualifying study sites, across multiple therapeutic areas including dermatology, respiratory, and cardiology, to name a few. Over the last 8 years, Dilek has been responsible for operationalizing Clariness’ patient recruitment strategies, engaging and randomizing patients on a global scale.